Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are taking a beating today on the back of earnings that did not live up to Wall Street expectations. The stock is trading down over 15% to $100.00. After analyzing the stock closely, I found that there is no solid support until a double bottom at $92.00. Note the stock chart below. This is where I will be looking to buy this biotech company.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.